Addiction Medicine

Substance use, psychiatric symptoms, personal mastery, and social support among COVID-19 long haulers: A compensatory model
Cheuk Chi Tam, Shan Qiao, Camryn Garrett, Ran Zhang, Atefeh Aghaei, Abhishek Aggarwal, Xiaoming Li

medRxiv 2022.11.23.22282679; doi: https://doi.org/10.1101/2022.11.23.22282679

Add to Selected Citations
Patterns of Polysubstance use in young Black and Latinx sexual minority men and transgender women in its association with sexual partnership factors: The PUSH study
Renata Arrington-Sanders, Noya Galai, Oluwaseun Falade-Nwulia, Christopher Hammond, Andrea Wirtz, Christopher Beyrer, David Celentano

medRxiv 2022.11.10.22282192; doi: https://doi.org/10.1101/2022.11.10.22282192

Add to Selected Citations
DNA Methylation in Cocaine Use Disorder – An Epigenome-wide Approach in the Human Prefrontal Cortex
Eric Poisel, Lea Zillich, Fabian Streit, Josef Frank, Marion M Friske, Jerome C Foo, Naguib Mechawar, Gustavo Turecki, Anita C Hansson, Markus M Nöthen, Marcella Rietschel, Rainer Spanagel, Stephanie H Witt

medRxiv 2022.11.05.22281974; doi: https://doi.org/10.1101/2022.11.05.22281974

Add to Selected Citations
Increased lipid peroxidation and lowered antioxidant defenses predict methamphetamine induced psychosis
Hussein Kadhem Al-Hakeim, Mazin Fadhil Altufaili, Abbas F. Almulla, Shatha Rouf Moustafa, Michael Maes

medRxiv 2022.10.26.22281566; doi: https://doi.org/10.1101/2022.10.26.22281566

Add to Selected Citations
Initial Insights from a Quality Improvement Initiative to Develop an Evidence-informed Young Adult Substance Use Program
Jillian Halladay, Victoria Stead, Catherine McCarron, Marina Kennedy, Kyla King, Michelle Venantius, A. Carter, Sabrina Syan, Mareena Matthews, Saba Khoshroo, Myra Massey, Liah Rahman, Jacinda Burns, Kiran Punia, Emily MacKillop, Holly Raymond, James MacKillop

medRxiv 2022.10.21.22281362; doi: https://doi.org/10.1101/2022.10.21.22281362

Add to Selected Citations
ALCOHOLIC LIVER BIOMARKERS: DETERMINANTS FOR ADMISSION TO REHABILITATION CENTRES DURING THE COVID 19 PERIOD IN KENYA
George Njoroge, Catherine Mwenda, Ezekiel Mecha, Stanley Waithaka

medRxiv 2022.10.18.22281212; doi: https://doi.org/10.1101/2022.10.18.22281212

Add to Selected Citations
The Novel Psychoactive Substances Epidemic: a Scientometric Perspective
Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, Ornella Corazza, Aurora Coppola, Gianluca Esposito

medRxiv 2022.10.16.22281132; doi: https://doi.org/10.1101/2022.10.16.22281132

Add to Selected Citations
Using synthetic controls to estimate the population-level effects of Ontario’s recently implemented overdose prevention sites and consumption and treatment services
Dimitra Panagiotoglou, Jihoon Lim

medRxiv 2021.12.13.21267739; doi: https://doi.org/10.1101/2021.12.13.21267739

Add to Selected Citations
Trends in opioid seizure data and their association with opioid mortality
Heather McBrien, Monica Alexander

medRxiv 2022.10.08.22280845; doi: https://doi.org/10.1101/2022.10.08.22280845

Add to Selected Citations
Disparities in Naltrexone Prescriptions to Medicaid Enrollees During the COVID-19 Pandemic
Hemmy A. Subervi, Lysine E. Varghese, Brian J. Piper

medRxiv 2022.10.05.22280706; doi: https://doi.org/10.1101/2022.10.05.22280706

Add to Selected Citations

Addiction Medicine

Pages